Showing results (1011-1020 of 1,984) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|October 24, 2015
Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trialClaudia Trenkwalder, K Ray Chaudhuri, Pablo Martinez-Martin, et al.
The Lancet. Neurology|June 16, 2016
Dementia in Down's syndromeClive Ballard, William Mobley, John Hardy, et al.
The Lancet. Neurology|June 16, 2016
Epigenetics of dementia: understanding the disease as a transformation rather than a stateBryan Maloney, Debomoy K Lahiri
The Lancet. Neurology|June 16, 2016
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trialRafael de la Torre, Susana de Sola, Gimena Hernandez, et al.
The Lancet. Neurology|June 16, 2016
Advances in the development of biomarkers for epilepsyAsla Pitkänen, Wolfgang Löscher, Annamaria Vezzani, et al.
The Lancet. Neurology|June 16, 2016
Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyondElise Cuyvers, Kristel Sleegers
The Lancet. Neurology|June 16, 2016
Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophyVolker Straub, Pavel Balabanov, Kate Bushby, et al.
The Lancet. Neurology|August 22, 2015
Mitochondrial dysfunction and seizures: the neuronal energy crisisGábor Zsurka, Wolfram S Kunz
The Lancet. Neurology|May 3, 2016
Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort studySolène Moulin, Julien Labreuche, Stéphanie Bombois, et al.
The Lancet. Neurology|December 2, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trialRhonda R Voskuhl, HeJing Wang, T C Jackson Wu, et al.
Pageof 199